AVR 0.53% $18.60 anteris technologies ltd

hsv2 final results

  1. 1,649 Posts.
    lightbulb Created with Sketch. 50
    gday,

    wanted to start a discussion on what to expect and how to interpret the upcoming results.  Given that we are now in april they can drop at any time.  

    As i understand it genocea currently have the results we need to compare against as their final phase 2 results are the best out there.  Below is a table of their results.  

    IMG_1213.PNG

    as i don't have a medical background i'm not entirely sure exactly which figures to compare against (hopefully some with appropriate education and background could help here)

    Comparing the interim AHZ results against this table, i believe we compare to dose 3 column (as this is what was reported in the interim results)  link to announcement here

    http://www.asx.com.au/asxpdf/20161019/pdf/43c35546jbmprc.pdf

    my humble interpretation:
    admedus vs genocea at interim stage
    shedding: 58 v 41%
    lesions: 81 v 62%

    so i believe these next round of results are going to be compared to the last column of genoceas results being the 12 months column.

    that is my interpretation, probably wrong but a starting point for us.

    those in the know please continue on from here.  

    very excited for this month and good luck
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.60
Change
-0.100(0.53%)
Mkt cap ! $357.5M
Open High Low Value Volume
$18.70 $18.77 $18.21 $664.1K 35.88K

Buyers (Bids)

No. Vol. Price($)
1 1000 $18.50
 

Sellers (Offers)

Price($) Vol. No.
$18.69 53 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.